These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36427536)

  • 1. Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.
    Brown GC; Brown MM; Sharma S
    Can J Ophthalmol; 2024 Feb; 59(1):24-30. PubMed ID: 36427536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision-Related Quality of Life Associated with Unilateral and Bilateral Ocular Conditions.
    Brown GC; Brown MM; Stein JD; Smiddy WE;
    Ophthalmology; 2018 Jul; 125(7):965-971. PubMed ID: 29477690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.
    Brown GC; Brown MM; Chaudhry I; Stein JD
    JAMA Ophthalmol; 2021 Apr; 139(4):389-397. PubMed ID: 33538789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life associated with no light perception vision.
    Brown GC; Brown MM; Stein JD; Sharma S
    Can J Ophthalmol; 2023 Aug; 58(4):361-368. PubMed ID: 35472297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vision-related quality-of-life estimates in adolescent youths.
    Stevens W; Brown GC; Brown MM; Stein JD; Sharma S
    Can J Ophthalmol; 2021 Dec; 56(6):385-390. PubMed ID: 33592178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision utilities in Italy and the United States: Comparison of time tradeoff vision utilities.
    De Salvo G; Brown GC; Brown MM
    Eur J Ophthalmol; 2020 Mar; 30(2):253-257. PubMed ID: 30696257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes.
    Brown MM; Brown GC; Sharma S; Smith AF; Landy J
    Int Ophthalmol; 2001; 24(3):123-7. PubMed ID: 12498507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment.
    Fenwick EK; Ozdemir S; Man REK; Baid D; Htoon HM; Gan ATL; Tey ML; Aw AT; Baskaran M; Nongpiur ME; Finkelstein EA; Tey CS; Soon HJT; Sabanayagam C; Sng CCA; Wong TY; Husain R; Perera SA; Lun K; Aung T; Lamoureux EL
    JAMA Ophthalmol; 2021 Aug; 139(8):866-874. PubMed ID: 34165504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility and uncorrected refractive error.
    Tahhan N; Papas E; Fricke TR; Frick KD; Holden BA
    Ophthalmology; 2013 Sep; 120(9):1736-44. PubMed ID: 23664469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument.
    Richardson J; Iezzi A; Peacock S; Sinha K; Khan M; Misajon R; Keeffe J
    Ophthalmic Epidemiol; 2012 Jun; 19(3):172-82. PubMed ID: 22568431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of health and vision utilities in low vision patients.
    Malkin AG; Goldstein JE; Massof RW
    Optom Vis Sci; 2012 Mar; 89(3):288-95. PubMed ID: 22227913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision and quality of life: development of methods for the VisQoL vision-related utility instrument.
    Peacock S; Misajon R; Iezzi A; Richardson J; Hawthorne G; Keeffe J
    Ophthalmic Epidemiol; 2008; 15(4):218-23. PubMed ID: 18780254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.
    van de Graaf ES; Despriet DDG; Klaver CCW; Simonsz HJ
    BMC Ophthalmol; 2016 May; 16(1):56. PubMed ID: 27184381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.